Tenofovir-associated bone density loss

Clinical observations have revealed a strong correlation between loss of bone density in HIV-infected individuals, particularly in conjunction with the antiretroviral drug tenofovir, a nucleotide analog that inhibits HIV reverse transcriptase. The most compelling correlations have been observed in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigsby, Iwen F, Pham, Lan, Mansky, Louis M, Gopalakrishnan, Raj, Mansky, Kim C
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Mini – Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817787/
https://www.ncbi.nlm.nih.gov/pubmed/20169035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817787/
https://www.ncbi.nlm.nih.gov/pubmed/20169035

Ejemplares similares